The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
On May 16, Glucotrack received a Nasdaq delisting notice for failing to maintain a minimum bid price of $1.00 and the $2.5 million stockholders' equity requirement. The company intends to request a hearing by May 18, 2026, which would temporarily stay the delisting process.